de Guillebon, Eleonore https://orcid.org/0009-0004-9590-528X
He, Celestine
Akhtar, Saadia
Pietrzak, Robert H.
Ripp, Jonathan
Peccoralo, Lauren
Article History
Received: 9 April 2024
Accepted: 10 September 2024
First Online: 1 October 2024
Declarations:
:
: Lauren Peccoralo and Jonathan Ripp were partially supported by HRSA grant U3NHP45398 and Lauren Peccoralo was partially supported by the CTSA grant UL1TR004419 from the National Center for Advancing Translational Sciences, by the AMA EHR Use Research Grant and the NIH FIRST Cohort Cluster Hiring U54 CA267776. Lauren Peccoralo received honoraria from Chinese American Medical Society, Maine Medical Center, Atrium Health Wake Forest Baptist, American Society of Health-System Pharmacists, Stanford University, University of Montana and Baylor, and Scott & White Health. Jonathan Ripp received honoraria for numerous speaking engagements at professional societies, academic medical centers, and healthcare institutions; serves as a course director for the Institute for Healthcare Improvement; worked as a consultant for the well-being program at the NYU School of Medicine Long Island; served as a non-fiduciary board member of the Lorna Breen Foundation; served on a temporary advisory board established by PEPSICO to inform employee well-being efforts; and provides consultation to Marvin Behavioral Health, Inc. Robert H. Pietrzak is a research consultant to the Office of Well-Being and Resilience at the Icahn School of Medicine at Mount Sinai. Robert H. Pietrzak and Eleonore de Guillebon declare that they do not have a conflict of interest.
: Presented by Eleonore de Guillebon at the American Conference of Physician Health on October 12, 2023.
: Exempt status determined by the Mount Sinai Health System IRB on June 23, 2022.